The recent Harvard stop-work order signifies a major disruption in critical research activities, particularly those led by renowned scientist Don Ingber at the Wyss Institute.This halt, triggered after a funding freeze from the federal government, affects over $19 million in ongoing projects focusing on groundbreaking organ-on-a-chip technology.
